Best Healthcare Companies in Beijing, China
The 187 best Healthcare companies in Beijing, China in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Haoyisheng.
Ranked: Best Healthcare companies in Beijing
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Haoyisheng Provider of medical data management, channel communication, and marketing services for hospitals | $500M | 121 mo ago | Series A | — | Edwin NG CEO | JavaNginxjQuery | — | — |
| 2 | Pharmaron Suite of drug discovery and development services for small molecules | $320M | 126 mo ago | Public | 476 | Larry Lou Co-Founder | WordPress Block EditorWordPressMySQL+23 | — | — |
| 3 | Chemclin Provider of in vitro diagnostics instruments and auxiliary reagents | $313M | 94 mo ago | Acquired | 658 | — | — | — | — |
| 4 | Beijing Biostar Technologies Developer and manufacturer of APIs, intermediates, & biochemical reagents | $135M | 66 mo ago | Public | 148 | Qiu Rongguo Co-CEO | — | — | — |
| 5 | Sanbo Brain Hospital Standalone neurology hospital | $113M | 73 mo ago | Series B | 1,733 | — | Animate.cssNginxHSTS | — | — |
| 6 | Concordmedical Radiotherapy and diagnostic imaging centers | $100M | 75 mo ago | Public | 893 | — | PHPWindows ServerThinkPHP+5 | — | — |
| 7 | Riel Dental Chain of dental clinics | $90M | 105 mo ago | Deadpooled | 307 | — | — | — | — |
| 8 | Lu Daopei Hospital Chain of haematology & oncology treatment hospital | $87M | 69 mo ago | Series B | 1,641 | Daopei Lu Founder | — | — | — |
| 9 | Biliansheng hair Chain of hair clinics | $77M | 101 mo ago | Series C | 600 | — | — | — | — |
| 10 | Lu Daopei Medical Group Standalone hematology hospital | $72M | 70 mo ago | Series B | — | Lu Daopei Founder | PHPAnimate.cssNginx+4 | — | — |
| 11 | Advaccine Biotech Developer of preventive and therapeutic vaccines | $70M | 62 mo ago | Series B | 191 | Jane YU CEO | — | — | — |
| 12 | Bellen Chemistry Research and manufacturing of API and intermediates, while specializing in heterocycles | $53M | 71 mo ago | Series D | 1,000 | — | — | — | — |
| 13 | Igengmei Provider of wood finishing services for construction materials | $50M | 94 mo ago | Series D | — | Liu Di Founder & CEO | Node.jsBaidu MapsEnvoy+5 | — | — |
| 14 | Yiming Provider of research and cell & gene therapy development services | $49M | 57 mo ago | Deadpooled | — | — | — | 136 patents Patents concentrated in electrical & electronics | — |
| 15 | Gan & Lee Pharmaceutical Developer and commercializer of insulin analogs and medical devices | $46M | 181 mo ago | Series B | 4,057 | Zhongru Gan Founder | LayuiNginxSwiper+4 | — | 1 expansion |
| 16 | Zhixin Medical Provider of supply chain for medical consumables | $39M | 100 mo ago | Public | 1,047 | — | — | — | — |
| 17 | Jinsong Dental Standalone dental hospital | $30M | 105 mo ago | Series B | — | Ma Zhixin CEO | — | — | — |
| 18 | Beijing Meilian Tyco Biotechnology Manufacturer of pathology and diagnostic products | $30M | 56 mo ago | Series C | 200 | — | — | — | — |
| 19 | CHIGENOVO Biotechnology company focused on developing gene therapy drugs for eye diseases | $26M | 32 mo ago | Series A | — | Zhong Xiancheng CEO | — | 41 patents AAV‑based gene therapy and editing platforms for inherited retinal dystrophies | — |
| 20 | GENFINE Biotech Manufacturer and supplier of pharmaceutical products | $23M | 64 mo ago | Series A | — | Yang Liang Founder & CEO | — | — | — |
| 21 | Beijing Nokangda Pharmaceutical Technology Provider of preclinical, clinical drug development and drug delivery services | $23M | 112 mo ago | Series A | 310 | Chen Peng CEO | — | — | — |
| 22 | Photonic Bridges Developer of Windows system utilities and productivity software | $23M | 277 mo ago | Acquired | 300 | — | — | — | — |
| 23 | Symbow Medical Provider of research, development, production and sales of early functional imaging technology for tumors &… | $18M | 107 mo ago | Series A | 40 | Lei Zhao CEO | — | — | — |
| 24 | PharmCube Big Data platform offering pharmaceutical data | $16M | 69 mo ago | Series B | 40 | — | Node.jsUnoCSSTailwind CSS+10 | — | — |
| 25 | Beijing Wanjie Tianyuan Medical Equipment Manufacturer of orthopedic rehabilitation devices and other medical equipments | $15M | 61 mo ago | Series B | 125 | — | — | — | — |
| 26 | Laviana Pharma Contract development services provider | $15M | 81 mo ago | Series B | — | Wenting Chen Chairman & CEO | — | — | — |
| 27 | Mengmei Life Provider of IVF medical consultation services | $15M | 87 mo ago | Series A | 3 | — | Windows ServerMicrosoft ASP.NETBootstrap+7 | — | — |
| 28 | Demei Medical Manufacturer of arthroscopic devices | $15M | 64 mo ago | Series E | — | Jason Lee Founder | — | — | — |
| 29 | Vas Medical Manufacturer of vascular interventional surgery robots and their consumables | $15M | 39 mo ago | Seed | — | Li Jin Co-Founder | — | — | — |
| 30 | Beijing Ruifen Biotechnology R&D company focused on manufacturing of plant functional ingredients | $14M | 5 mo ago | Series C | 200 | Wang Xiaoyun CEO | — | — | — |
| 31 | ICE Bioscience Specialised CRO offering a range of screening platforms for cardiac safety testing, ion channel profiling and… | $14M | 25 mo ago | Series C | 19 | Li Yan CEO | anime.jsYouTubeNginx+7 | — | — |
| 32 | Beijing Origin Juhe Biotechnology Manufacturer of smart medical diagnostics devices | $14M | 29 mo ago | Series B | — | Pei Liu Founder | — | — | — |
| 33 | Blue Sail Surgery Provider of surgical instruments | $14M | 24 mo ago | Series A | 7,373 | Zhong Shuqiao CEO | NginxSwiperSweetAlert+2 | — | — |
| 34 | Bohui Ruijin Provider of biomaterials & surgical implant | $13M | 114 mo ago | Series B | — | Zhao Bo Founder | — | — | 4 launchs |
| 35 | Health Force (Beijing) Medical Technology Provider medical equipment maintenance & repair services | $12M | 96 mo ago | Series A | — | Main Haiwen Founder & CEO | — | — | — |
| 36 | EB Medical Manufacturer of intraocular lenses and delivery systems | $10M | 98 mo ago | Series C | 507 | — | Animate.cssApache HTTP ServerSlick+2 | — | — |
| 37 | Xinyun Medical Healthcare consortium offering consulting services to healthcare providers | $3M | 9 mo ago | Series B | 100 | Zhao Yun Founder & CEO | — | — | — |
| 38 | Beijing Fanxing Medical Technology Chain of cosmetic procedures clinics | $2M | 101 mo ago | Deadpooled | — | Liu Tengfei Co-Founder & CEO | — | — | — |
Top 12 Healthcare companies in Beijing
#1
Series C · Haidian, Beijing · founded 2007 · 200 employees$14.2Mraised▾
R&D company focused on manufacturing of plant functional ingredients
- Dec 2025Series C$14.2M
- Oct 2021Series B—
- Apr 2021Series A—
#2
Series B · Changping District, Beijing · founded 2016 · 100 employees$3Mraised▾
Healthcare consortium offering consulting services to healthcare providers
- Sep 2025Series B—
- Apr 2019Series A$3M
#3
Series A · Beijing, Beijing · founded 2020 · 7373 employees$13.8Mraised▾
Provider of surgical instruments. It offers a wide range of surgical products in general surgery, thoracic surgery, urology, and gynecology.
- May 2024Series A$13.8M
#4
Series C · Beijing, Beijing · founded 2010 · 19 employees$14Mraised▾
ICE Bioscience is a specialised preclinical CRO offering ion channel based screening services through their expertise in electrophysiology. They offer a range of services for cardiac safety screening (hERG screening, QT-prolongation etc.), ion channel profiling (Voltage-gated, ion-gated, and other channels (CRAC and chloride channels)) and in-vitro high-throughput screening (GPCR and Protein Kinase assays, cell line generation etc.)
- May 2024Series C—
- Sep 2022Series B$14M
#5
Series A · Changping District, Beijing · founded 2016$26.5Mraised▾
Biotechnology company focused on developing gene therapy drugs for eye diseases. It is a high-tech enterprise focusing on gene therapy drug development and genetic diagnosis for inherited eye diseases.
- Oct 2023Series A—
- Mar 2022Series A$15.7M
- Mar 2021Seed$10.7M
#6
Series A · Beijing, Beijing · founded 1999$500Mraised▾
Provider of medical data management, channel communication, and marketing services for hospitals
- May 2016Series A$500M
#7
Public · Beijing, Beijing · founded 2003 · 476 employees$320Mraised▾
Pharmaron offers a suite of drug discovery and development services for small molecules, nucleosides, nucleotides, peptides, lipids and carbohydrates. They offer their R&D services across a number of disciplines including chemistry, biology, DMPK, pharmacology, toxicology and chemical and formulation development. The company claims that their chemistry division is one of the largest chemistry service providers in the world with experience and expertise in organic synthesis, library/high-throughput synthesis, chiral chemistry, medicinal, computational and cheminformatics, bioorganic chemistry, process and scale-up, analytical and purification. Their biologics division offers services such as antibody/protein engineering, antibody humanization, cell line development, recombinant antibody production, protein expression, purification, and characterization.The company has acquired Xceleron and SNBL CPC to augment its offerings.
- Dec 2015PE$280M
- Mar 2011Series C$40M
- Sep 2009Grant (prize money)$818.3K
- Sep 2009Grant (prize money)$818.3K
#8
Series B · Beijing, Beijing · founded 2020$14Mraised▾
Manufacturer of smart medical diagnostics devices
- Dec 2023Series B$14M
- Apr 2022Series A—
- Jun 2021Seed—
- Oct 2020Angel—
#9
Acquired · Beijing, Beijing · founded 2007 · 658 employees$312.5Mraised▾
Beijing Chemclin Biotech Co is a fully-owned subsidiary of the China Diagnostics Medical Corporation, a leading diagnostic company that specializes in the development, manufacturing and distribution of In Vitro Diagnostic reagents and instruments. The company develops diagnostic reagents covering chemiluminescence immunoassays, radioimmunoassay, and clinical chemistry assays. It provides radioimmunoassay or immunoradiometric assay kits as well as chemiluminescence immunoassay systems for in-vitro diagnostics, such as reagents, infectious diseases, tumor markers, liver fibrosis, diabetes, thyroid, and fertility.
- Aug 2018Series C$292M
- Oct 2008Series B$16.5M
- Apr 2007Series A$4M
#10
Public · Beijing, Beijing · founded 2002 · 148 employees$135.2Mraised▾
Beijing Biostar Technologies develops and manufactures APIs, intermediates, and biochemical reagents. The company offers development services including biomedical development, technology and transfer of anti-tumor small molecules, and technical service consulting.
- Nov 2020Series E$135.2M
- Jan 2019Series B—
#11
Series B · Haidian, Beijing · founded 2004 · 1733 employees$113Mraised▾
Standalone neurology hospital
- May 2020Series B$113M
#12
Series B · Beijing, Beijing · founded 2016 · 191 employees$70.3Mraised▾
Developer of preventive and therapeutic vaccines
- Mar 2021Series B$66M
- Feb 2020Series A$4.3M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.